India’s Sun Pharmaceutical Industries Ltd Gets FDA Nod for Octreotide Injection

August 17, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

MUMBAI, Aug 17 (Reuters) - Indian drug maker Sun Pharmaceutical Industries Ltd. has received approval from the U.S. Food and Drug Administration to make and market octreotide injection, the regulator's Web site showed.

Twitter
LinkedIn
Facebook
Email
Print

FDA Approvals Asia

Food and Drug Administration (FDA)